Shield Therapeutics plc (STX) Ordinary Shares 1.5p
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
153.00p
152.90p
196.00p
£179.30 million
153.00p
152.00p
53.75p
n/a
1.50p (0.97%) Previous:
1.50p
52,721
n/a
2,000
Performance
| 1 week 1W | 4.38% | 1 year 1Y | 172% |
|---|---|---|---|
| 1 month 1M | 5.26% | 2 years 2Y | 524.49% |
| 3 months 3M | 16.85% | 3 years 3Y | 9.2% |
| 6 months 6M | 15.93% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue (£m) | 11.88 | 0.64 |
| Profit before tax (£m) | (5.15) | (20.99) |
| Adjusted EPS (p): | (2.00) | (17.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 2) -
Sell
(0 of 2) -
Neutral
(1 of 2) -
Buy
(0 of 2) -
Strong Buy
(1 of 2)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Shield Therapeutics details year of 'material progress'
27 January 2020 08:09
-
Shield Therapeutics narrows loss as it pursues further Feraccru approval
7 August 2019 10:27
-
Shield Therapeutics shares leap as FDA approves Feraccru
26 July 2019 13:02
-
Holding(s) in Company
21 February 2020 11:14
-
Hardman & Co Research: Shield Therapeutics (STX): Good demand for Feraccru in Europe
28 January 2020 12:15
-
Business and trading update
27 January 2020 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.